Diet, Microbiome and Health 2018
DOI: 10.1016/b978-0-12-811440-7.00003-x
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Aspects of Probiotics and Prebiotics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 140 publications
0
9
0
Order By: Relevance
“…Bacterial fermentation of prebiotic carbohydrates results in the production of short-chain fatty acids (SCFAs) such as butyric acid, acetic acid or propionic acid [22]. Prebiotics and the SCFAs are crucial for intestinal health, stimulate the immune system, can be a source of energy for gut microbiota, and have antagonistic properties to detrimental gut bacteria [60][61][62]. Moreover, numerous experimental studies have proved that prebiotics can help decrease the severity of particular diseases such as mental disorders, diabetes, irritable bowel syndrome (IBS), infectious diseases and reduce the colon cancer risk [63,64].…”
Section: Prebioticsmentioning
confidence: 99%
“…Bacterial fermentation of prebiotic carbohydrates results in the production of short-chain fatty acids (SCFAs) such as butyric acid, acetic acid or propionic acid [22]. Prebiotics and the SCFAs are crucial for intestinal health, stimulate the immune system, can be a source of energy for gut microbiota, and have antagonistic properties to detrimental gut bacteria [60][61][62]. Moreover, numerous experimental studies have proved that prebiotics can help decrease the severity of particular diseases such as mental disorders, diabetes, irritable bowel syndrome (IBS), infectious diseases and reduce the colon cancer risk [63,64].…”
Section: Prebioticsmentioning
confidence: 99%
“…Oligosaccharides such as inulin, FOS, GOS, soybean-oligosaccharide (SOS), lactulose, lactosucrose, xylo-oligosaccharides (XOS), isomalto-oligosaccharides (IOS) and resistant starch (Vinayak, et al, 2021) possess low molecular weight and cannot be digested by humans due to the absence of enzymes catalyzing them, but can be utilized by healthy microbes (probiotics) in the digestive tract (Al-Sheraji, et al, 2013;Khangwal & Shukla, 2019;Quigley, 2019;Vinayak, et al, 2021). Dominant probiotics such as Lactobacillus and Bifidobacteria are able to ferment prebiotics and generate SCFA such as butyric acid, acetic acid, lactic acid and propionic acid (Ahmad & Khalid, 2018;Vinayak, et al, 2021) associated with the increased function of mineral absorption, digestion, glucose regulation, and lipid metabolism (Sarao, & Arora, 2017). If probiotics thrive in the digestive tract, the growth of pathogenic bacteria is inhibited.…”
Section: Resultsmentioning
confidence: 99%
“…Prebiotics are recognised for their ability to manipulate host microbiota to the benefit of the host (Gibson et al ., ). Currently fructans (Ahmad & Khalid, ; Bajury et al ., ; Joshi et al ., ), inulin (Ahmadi et al ., ; Fu et al ., ; Heydari et al ., ) and galactans (Cremon et al ., ; Fehlbaum et al ., ; Ndeh & Gilbert, ), fit this definition of prebiotics. Prebiotic products have a strong science background from positive clinical trials but have yet to obtain regulator‐approved health claims from the European Food Safety Authority (EFSA) in Europe.…”
Section: Prebioticsmentioning
confidence: 99%